Abstract
Background At the present time, optimization of dietary and fitness practices are inadequately addressed in the clinical setting, and poorly documented through research studies investigating response to surrogate disease markers. Identifying and quantifying the personal response to lifestyle interventions requires a new tool and a new measurement metric.
Methods In this prospective observational study, COR.RELATE study, we investigated the effect of four lifestyle interventions, each spanning 21 days and consisting of seven validated practices, in a healthy population. We used a novel at-home near-infrared spectrometer (wavelength 1600-2450 nm), COR console, to measure the spectral blood changes in a cohort of 178 healthy males and females who participated in four 21-day cycles of lifestyle programs. In the first round, study participants also completed dried blood spot cards, provided by omega quant, at the start and end of their program.
Results We analyzed 1,870 infrared spectroscopy samples from 178 participants (131 males and 47 females) who participated in the first four programs of COR.RELATE. We found on average 79.75% of the participants are responsive to one or more of the COR programs. We describe an algorithmic approach, ranking personal responses to different nutrition and fitness interventions.
Conclusion The COR console and data analytics enables the use of a novel near-infrared based metric--which we call the COR Blood Response Pattern (BRP)--to measure individual response to lifestyle change, and has the sensitivity to discern, classify, and rank the success of rapid lifestyle interventions in terms of the correlated spectroscopic response they produce. Rapid Lifestyle Prototyping is a new concept in consumer life optimization and improvement - the ability to know in no more than 21 days whether a particular single, or set of, lifestyle practices is going to evoke a strong response for an individual and therefore if it is worth continuing that practice in their quest for deep optimization and life improvement.
Competing Interest Statement
T. Quertermous and E. Andries are consultants to Nueon Inc (dbs "COR"). Other authors are or have been employees of Nueon Inc (dbs "COR").
Clinical Trial
Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) do not require registration and this was cleared with the IRB.
Funding Statement
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Advarra IRB has reviewed and approved the protocol (NUEON INC - DOC-003-005, The COR.RELATE Study (Pro00049404)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author, [TQ]. The data are not publicly available due to [restrictions e.g. their containing information that could compromise the privacy of research participants
